Citigroup Inc Teva Pharmaceutical Industries LTD Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citigroup Inc holds 1,112,622 shares of TEVA stock, worth $18.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,112,622
Previous 4,069,266
72.66%
Holding current value
$18.5 Million
Previous $62.5 Million
70.19%
% of portfolio
0.01%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding TEVA
# of Institutions
653Shares Held
663MCall Options Held
30.2MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$714 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$639 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$637 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$627 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$627 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...